NALD2_HUMAN - dbPTM
NALD2_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID NALD2_HUMAN
UniProt AC Q9Y3Q0
Protein Name N-acetylated-alpha-linked acidic dipeptidase 2
Gene Name NAALAD2
Organism Homo sapiens (Human).
Sequence Length 740
Subcellular Localization Cell membrane
Single-pass type II membrane protein .
Protein Description Has N-acetylated-alpha-linked-acidic dipeptidase (NAALADase) activity. Also exhibits a dipeptidyl-peptidase IV type activity. Inactivate the peptide neurotransmitter N-acetylaspartylglutamate..
Protein Sequence MAESRGRLYLWMCLAAALASFLMGFMVGWFIKPLKETTTSVRYHQSIRWKLVSEMKAENIKSFLRSFTKLPHLAGTEQNFLLAKKIQTQWKKFGLDSAKLVHYDVLLSYPNETNANYISIVDEHETEIFKTSYLEPPPDGYENVTNIVPPYNAFSAQGMPEGDLVYVNYARTEDFFKLEREMGINCTGKIVIARYGKIFRGNKVKNAMLAGAIGIILYSDPADYFAPEVQPYPKGWNLPGTAAQRGNVLNLNGAGDPLTPGYPAKEYTFRLDVEEGVGIPRIPVHPIGYNDAEILLRYLGGIAPPDKSWKGALNVSYSIGPGFTGSDSFRKVRMHVYNINKITRIYNVVGTIRGSVEPDRYVILGGHRDSWVFGAIDPTSGVAVLQEIARSFGKLMSKGWRPRRTIIFASWDAEEFGLLGSTEWAEENVKILQERSIAYINSDSSIEGNYTLRVDCTPLLYQLVYKLTKEIPSPDDGFESKSLYESWLEKDPSPENKNLPRINKLGSGSDFEAYFQRLGIASGRARYTKNKKTDKYSSYPVYHTIYETFELVEKFYDPTFKKQLSVAQLRGALVYELVDSKIIPFNIQDYAEALKNYAASIYNLSKKHDQQLTDHGVSFDSLFSAVKNFSEAASDFHKRLIQVDLNNPIAVRMMNDQLMLLERAFIDPLGLPGKLFYRHIIFAPSSHNKYAGESFPGIYDAIFDIENKANSRLAWKEVKKHISIAAFTIQAAAGTLKEVL
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
43PhosphorylationETTTSVRYHQSIRWK
CCCCHHHHHHHHHHH
11.31-
62PhosphorylationMKAENIKSFLRSFTK
HHHHHHHHHHHHHCC
26.2224719451
66PhosphorylationNIKSFLRSFTKLPHL
HHHHHHHHHCCCHHH
39.1424719451
111N-linked_GlycosylationDVLLSYPNETNANYI
EEEECCCCCCCCCEE
61.5619678840
143N-linked_GlycosylationPPPDGYENVTNIVPP
CCCCCCCCCCCCCCC
37.11UniProtKB CARBOHYD
185N-linked_GlycosylationLEREMGINCTGKIVI
HHHHHCCCCCCEEEE
16.1519678840
314N-linked_GlycosylationKSWKGALNVSYSIGP
CCCCCCEEEEEEECC
21.83UniProtKB CARBOHYD
328PhosphorylationPGFTGSDSFRKVRMH
CCCCCCHHHHEEEEE
28.75-
341AcetylationMHVYNINKITRIYNV
EEEEEHHHHHEEEEE
41.4812430273
449N-linked_GlycosylationSDSSIEGNYTLRVDC
CCCCCCCCEEEEEEC
17.5219678840
451PhosphorylationSSIEGNYTLRVDCTP
CCCCCCEEEEEECHH
16.4624719451
507PhosphorylationPRINKLGSGSDFEAY
CCHHCCCCCCHHHHH
45.6329759185
522PhosphorylationFQRLGIASGRARYTK
HHHHCCCCCCCEECC
27.22-
527PhosphorylationIASGRARYTKNKKTD
CCCCCCEECCCCCCC
22.5330576142
528PhosphorylationASGRARYTKNKKTDK
CCCCCEECCCCCCCC
23.6930576142
603N-linked_GlycosylationNYAASIYNLSKKHDQ
HHHHHHHCCCHHHCH
35.85UniProtKB CARBOHYD
628N-linked_GlycosylationSLFSAVKNFSEAASD
HHHHHHHCHHHHHHH
38.7919678840

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of NALD2_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of NALD2_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of NALD2_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions

Oops, there are no PPI records of NALD2_HUMAN !!

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of NALD2_HUMAN

loading...

Related Literatures of Post-Translational Modification
N-linked Glycosylation
ReferencePubMed
"Structural insight into the evolutionary and pharmacologic homologyof glutamate carboxypeptidases II and III.";
Hlouchova K., Barinka C., Konvalinka J., Lubkowski J.;
FEBS J. 276:4448-4462(2009).
Cited for: X-RAY CRYSTALLOGRAPHY (1.29 ANGSTROMS) OF 36-740 ALONE AND IN COMPLEXWITH GLUTAMATE AND INHIBITORS, SUBUNIT, ZINC-BINDING SITES, ANDGLYCOSYLATION AT ASN-111; ASN-185; ASN-449 AND ASN-628.

TOP